Cryoport, Inc. (CYRX)
NASDAQ: CYRX · Real-Time Price · USD
19.89
-0.21 (-1.04%)
At close: Nov 13, 2026, 4:00 PM EST
19.81
-0.08 (-0.40%)
After-hours: Nov 13, 2026, 7:30 PM EST
Cryoport Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 192.44 | 176.18 | 156.77 | 168.66 | 237.28 | 222.61 | |
Revenue Growth | 11.77% | 12.38% | -7.05% | -28.92% | 6.59% | 182.87% |
Cost of Revenue | 102.16 | 93.12 | 87.11 | 93.33 | 133.4 | 126.03 |
Gross Profit | 90.28 | 83.05 | 69.66 | 75.33 | 103.87 | 96.58 |
Selling, General & Admin | 100.03 | 97.64 | 107.98 | 108.86 | 120.06 | 97.56 |
Research & Development | 17.96 | 17.04 | 17.71 | 18.04 | 15.72 | 16.84 |
Operating Expenses | 117.99 | 114.68 | 125.69 | 126.9 | 135.78 | 114.41 |
Operating Income | -27.71 | -31.63 | -56.04 | -51.57 | -31.9 | -17.83 |
Interest Expense | -2.1 | -2.36 | -3.98 | -5.58 | -6.14 | -4.69 |
Interest & Investment Income | 12.61 | 9.8 | 9.9 | 10.58 | 8.47 | 3.25 |
Currency Exchange Gain (Loss) | -0.56 | -1.6 | -3.2 | -6.4 | -3.8 | -10.7 |
Other Non Operating Income (Expenses) | -0.43 | -0.5 | 1.14 | 10.81 | -4.36 | 7.88 |
EBT Excluding Unusual Items | -18.2 | -26.29 | -52.18 | -42.17 | -37.74 | -22.09 |
Merger & Restructuring Charges | -0.36 | - | - | - | - | - |
Impairment of Goodwill | - | - | -54.56 | -49.57 | - | - |
Gain (Loss) on Sale of Investments | -6.15 | -0.7 | -5.04 | 1.24 | - | - |
Asset Writedown | - | - | -9.25 | - | - | - |
Other Unusual Items | -10.42 | -5.18 | 16.68 | 6.28 | - | -251.75 |
Pretax Income | -35.13 | -32.17 | -104.35 | -84.21 | -35.09 | -273.84 |
Income Tax Expense | 1.93 | 1.8 | 0.36 | 0.35 | 2.24 | 1.69 |
Earnings From Continuing Operations | -37.06 | -33.97 | -104.71 | -84.56 | -37.33 | -275.53 |
Earnings From Discontinued Operations | -4.24 | 112.27 | -10.05 | -15.03 | - | - |
Net Income | -41.3 | 78.3 | -114.76 | -99.59 | -37.33 | -275.53 |
Preferred Dividends & Other Adjustments | 8 | 8 | 8 | 8 | 8 | 8.2 |
Net Income to Common | -49.3 | 70.3 | -122.76 | -107.59 | -45.33 | -283.72 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 50 | 50 | 49 | 49 | 49 | 46 |
Shares Outstanding (Diluted) | 50 | 50 | 49 | 49 | 49 | 46 |
Shares Change | 0.51% | 1.46% | 1.26% | -0.51% | 6.66% | 19.04% |
EPS (Basic) | -0.98 | 1.40 | -2.49 | -2.21 | -0.93 | -6.18 |
EPS (Diluted) | -0.98 | 1.40 | -2.49 | -2.21 | -0.93 | -6.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -18.81 | -25.02 | -33.58 | -39.54 | -23.96 | -15.76 |
Free Cash Flow Per Share | -0.37 | -0.50 | -0.68 | -0.81 | -0.49 | -0.34 |
Gross Margin | 46.91% | 47.14% | 44.43% | 44.66% | 43.78% | 43.38% |
Operating Margin | -14.40% | -17.95% | -35.74% | -30.58% | -13.45% | -8.01% |
Profit Margin | -25.62% | 39.90% | -78.30% | -63.79% | -19.11% | -127.46% |
Free Cash Flow Margin | -9.77% | -14.20% | -21.42% | -23.45% | -10.10% | -7.08% |
EBITDA | 0.66 | -3.92 | -25.28 | -24.08 | -9.14 | 2.42 |
EBITDA Margin | 0.34% | -2.22% | -16.12% | -14.28% | -3.85% | 1.09% |
D&A For EBITDA | 28.37 | 27.71 | 30.76 | 27.49 | 22.77 | 20.25 |
EBIT | -27.71 | -31.63 | -56.04 | -51.57 | -31.9 | -17.83 |
EBIT Margin | -14.40% | -17.95% | -35.74% | -30.58% | -13.45% | -8.01% |
Revenue as Reported | 192.44 | 176.18 | 156.77 | 168.66 | 237.28 | 222.61 |